Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (276)

Search Parameters:
Keywords = hemoglobin regulation

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 732 KiB  
Article
L-Arginine Effect as an Additive on Overall Performance, Health Status, and Expression of Stress Molecular Markers in Nile Tilapia (Oreochromis niloticus) Under Chronic Salinity Exposure
by Andrea Itzel Munguía-Casillas, María Teresa Viana, Miroslava Vivanco-Aranda, Luis Eduardo Ruiz-González, Emyr Saul Peña-Marín and Oscar Basilio Del Rio-Zaragoza
Fishes 2025, 10(8), 387; https://doi.org/10.3390/fishes10080387 - 6 Aug 2025
Abstract
Growing freshwater fish in saline environments is being explored as a potential solution to the freshwater shortage. However, growing these organisms in suboptimal salinity conditions leads to chronic stress that can be challenging to manage. To address this goal, it is crucial to [...] Read more.
Growing freshwater fish in saline environments is being explored as a potential solution to the freshwater shortage. However, growing these organisms in suboptimal salinity conditions leads to chronic stress that can be challenging to manage. To address this goal, it is crucial to improve the health of fish through the use of dietary supplements. This study evaluated the effects of varying levels of arginine supplementation on the growth, health status, and expression of stress-related molecular markers in juveniles of Nile tilapia exposed to chronic salinity stress. The tilapia were fed four experimental diets supplemented with 0, 1, 2, and 3% of L-arginine (T0, T1, T2, and T3). After an acclimatization period, the tilapias were exposed to a salinity level of 20‰ for 57 days in a recirculating aquaculture system. Our findings revealed that overall performance parameters were significantly influenced by L-arginine supplementation, except for the condition factor, viscerosomatic index, and hepatosomatic index. Additionally, intermediate levels of L-arginine supplementation positively influenced various blood parameters, including hematological profiles (hemoglobin and leukocytes), blood chemistry (total protein, albumin, globulin, and triglycerides), and the frequency of certain nuclear abnormalities. Furthermore, L-arginine supplementation appeared to regulate the expression of molecular markers related to stress and the immune system. In conclusion, this study indicates that L-arginine supplementation can help alleviate the chronic stress caused by salinity in juvenile Nile tilapia. Full article
(This article belongs to the Special Issue Fish Hematology)
Show Figures

Figure 1

31 pages, 3963 KiB  
Review
Neuroglobin and Cytoglobin in Mammalian Nervous Systems: About Distribution, Regulation, Function, and Some Open Questions
by Stefan Reuss
Brain Sci. 2025, 15(8), 784; https://doi.org/10.3390/brainsci15080784 - 23 Jul 2025
Viewed by 444
Abstract
Globins are a class of globular proteins that function in the transportation or storage of oxygen. They are critical for cellular metabolism. Notable examples include hemoglobin, which is found in red blood cells, and myoglobin, which is present in muscle cells. Approximately two [...] Read more.
Globins are a class of globular proteins that function in the transportation or storage of oxygen. They are critical for cellular metabolism. Notable examples include hemoglobin, which is found in red blood cells, and myoglobin, which is present in muscle cells. Approximately two decades ago, a third globin, designated as neuroglobin, was identified, expressed predominantly in neuronal cells. This was followed two years later by the fourth, cytoglobin, found in cells of the fibroblast lineage, as well as in neuronal cell populations of the central and nervous systems. Both neuroglobin and cytoglobin have been found in the sensory and endocrine systems, albeit inconsistently, and it is thought that they are engaged in functions such as oxygen transport and storage, scavenging of free radicals, NO metabolism, peroxidase activity, and signaling functions. Neuroglobin is also expressed in astrocytes under challenging conditions. Common neuroscience methods were utilized to study the distribution and regulation of globin tissues and of single brain cells. Despite considerable overlap in the findings of various studies, some results deviate significantly from other studies. The potential causes of these discrepancies may include variations in detection methods, animal age and sex, time of day and year, and differing cell culture conditions. This review will explore factors that may influence functional aspects of globins and their detection in the mammalian brain. Full article
(This article belongs to the Section Neuropharmacology and Neuropathology)
Show Figures

Figure 1

16 pages, 3025 KiB  
Article
Efficacy of Poloxamer 188 in Experimental Myelosuppression Model Induced by Carboplatin in CBA Mice
by Arina V. Kholina, Natalya A. Borozdina, Victor A. Palikov, Evgeniy S. Mikhaylov, Irina N. Kravchenko, Renata A. Dalevich, Irina A. Pakhomova, Ekaterina N. Kazakova, Maria A. Timchenko, Alexander Ye. Yegorov, Maxim V. Molchanov, Artem M. Ermakov, Olga Y. Antonova, Olga Y. Kochetkova, Natalia M. Pankratova, Anton N. Pankratov, Elena V. Arshintseva, Sergey Y. Pushkin, Igor A. Dyachenko and Arkadiy N. Murashev
Int. J. Mol. Sci. 2025, 26(15), 7081; https://doi.org/10.3390/ijms26157081 - 23 Jul 2025
Viewed by 195
Abstract
Poloxamer 188 is a polymer that is used as a carrier and stabilizer of pharmacological agents. It has been demonstrated to enhance red blood cell and hemoglobin levels in healthy animals and in select clinical cases. The objective of this study was to [...] Read more.
Poloxamer 188 is a polymer that is used as a carrier and stabilizer of pharmacological agents. It has been demonstrated to enhance red blood cell and hemoglobin levels in healthy animals and in select clinical cases. The objective of this study was to assess the efficacy of Poloxamer 188 in CBA mice when administered repeatedly in the carboplatin-induced myelosuppression model. The mice were administered carboplatin once at a dose of 100 mg/kg, and then Poloxamer 188 was orally administered daily at doses of 10 mg/kg, 100 mg/kg, 500 mg/kg, and 1000 mg/kg for 7 and 21 days. Poloxamer 188 at a dose of 1000 mg/kg was found to bring the level of 2,3-bisphosphoglycerate in red blood cells close to control level (p = 0.1331 for the control group compared to Poloxamer at a dose 1000 mg/kg) already from day 8 of the study and in bone marrow resulted in regulation of genes responsible for hematopoiesis. G-GSF at day 8 and TNFα at day 22 gene expression was significantly decreased by 54% (p = 0.012) and 16% (p = 0.024), respectively, with Poloxamer 188 administration at a dose of 100 mg/kg. Additionally, in the bone marrow, the treatment was seen to exert a positive regulatory effect on the genes responsible for hematopoiesis. These findings are consistent with the observed increase in red blood cell by 6.7% (p = 0.001), hemoglobin by 4.7% (p = 0.0053), and reticulocyte percentage by 53.6% (p < 0.0001) following Poloxamer 188 administration at a dose of 1000 mg/kg in CBA mice with myelosuppression. Full article
(This article belongs to the Section Molecular Pharmacology)
Show Figures

Figure 1

29 pages, 1100 KiB  
Review
Epigenetic Regulation of Erythropoiesis: From Developmental Programs to Therapeutic Targets
by Ninos Ioannis Vasiloudis, Kiriaki Paschoudi, Christina Beta, Grigorios Georgolopoulos and Nikoletta Psatha
Int. J. Mol. Sci. 2025, 26(13), 6342; https://doi.org/10.3390/ijms26136342 - 30 Jun 2025
Viewed by 625
Abstract
Erythropoiesis, the process driving the differentiation of hematopoietic stem and progenitor cells to mature erythrocytes, unfolds through tightly orchestrated developmental stages, each defined by profound epigenetic remodeling. From the initial commitment of hematopoietic progenitors to the terminal enucleation of erythrocytes, dynamic changes in [...] Read more.
Erythropoiesis, the process driving the differentiation of hematopoietic stem and progenitor cells to mature erythrocytes, unfolds through tightly orchestrated developmental stages, each defined by profound epigenetic remodeling. From the initial commitment of hematopoietic progenitors to the terminal enucleation of erythrocytes, dynamic changes in chromatin accessibility, transcription factor occupancy, and three-dimensional genome architecture govern lineage specification and stage-specific gene expression. Advances in our understanding of the regulatory genome have uncovered how non-coding elements, including enhancers, silencers, and insulators, shape the transcriptional landscape of erythroid cells. These elements work in concert with lineage-determining transcription factors to establish and maintain erythroid identity. Disruption of these epigenetic programs—whether by inherited mutations, somatic alterations, or environmental stress—can lead to a wide range of hematologic disorders. Importantly, this growing knowledge base has opened new therapeutic avenues, enabling the development of precision tools that target regulatory circuits to correct gene expression. These include epigenetic drugs, enhancer-targeted genome editing, and lineage-restricted gene therapies that leverage endogenous regulatory logic. As our understanding of erythroid epigenomics deepens, so too does our ability to design rational, cell-type-specific interventions for red blood cell disorders. Full article
(This article belongs to the Special Issue New Advances in Erythrocyte Biology and Functions)
Show Figures

Figure 1

15 pages, 3067 KiB  
Article
The Whole Blood Transcriptomic Analysis in Sickle Cell Disease Reveals RUNX3 as a Potential Marker for Vaso-Occlusive Crises
by Safa Taha, Hawra Abdulwahab, Muna Aljishi, Ameera Sultan, Moiz Bakhiet, Salvatore Spicuglia and Mohamed Belhocine
Int. J. Mol. Sci. 2025, 26(13), 6338; https://doi.org/10.3390/ijms26136338 - 30 Jun 2025
Viewed by 400
Abstract
Sickle cell disease (SCD) is the most common hemoglobinopathy, caused by a mutation in the β-globin gene of hemoglobin. It predisposes patients to painful Vaso-occlusive crises (VOC) and multi-organ dysfunctions. The disease exhibits significant phenotypic variability, making it challenging to predict severity and [...] Read more.
Sickle cell disease (SCD) is the most common hemoglobinopathy, caused by a mutation in the β-globin gene of hemoglobin. It predisposes patients to painful Vaso-occlusive crises (VOC) and multi-organ dysfunctions. The disease exhibits significant phenotypic variability, making it challenging to predict severity and outcomes. This study aimed to characterize the whole blood gene expression profile of Bahraini SCD patients, identifying differentially expressed genes during steady-state (n = 10) and VOC (n = 10) compared to healthy controls (n = 8). Analysis revealed 2073 and 3363 dysregulated genes during steady-state and VOC, respectively, compared to controls, with 1078 genes differentially expressed during VOC versus steady-state. Gene Ontology (GO) enrichment analysis highlighted significant deregulation in immune and hematopoietic pathways, including down-regulation of critical genes for immune modulation and hematopoietic balance. Notably, the transcription factor RUNX3, involved in immune cell differentiation and inflammation, was among the 668 down-regulated genes. RUNX3 was four-fold down-regulated in microarray analysis, three-fold in PCR, and showed a mean protein concentration of 11.13 pg/mL during VOC compared to 457.93 pg/mL during steady-state (p < 0.01). These findings suggest that RUNX3 may serve as a potential biomarker for VOC. Future large-scale validation, additional proteomic studies, and functional investigations are recommended to confirm its clinical utility and significance. Full article
Show Figures

Figure 1

16 pages, 1811 KiB  
Article
Exceptional Heme Tolerance in Serratia plymuthica: Proteomic Insights into Oxidative Stress Adaptation in the Aedes aegypti Midgut
by Sâmella da Hora Machado, Rívea Cristina Custódio Rodrigues, Maria Aparecida Aride Bertonceli, Analiz de Oliveira Gaio, Gabriela Petroceli-Mota, Ricardo de Souza Reis, Marília Amorim Berbert-Molina, Vanildo Silveira and Francisco José Alves Lemos
Life 2025, 15(6), 950; https://doi.org/10.3390/life15060950 - 13 Jun 2025
Viewed by 623
Abstract
Serratia plymuthica, isolated from the midgut of Aedes aegypti, displays remarkable resilience to hemin, a toxic hemoglobin byproduct generated during blood digestion. This study explores its proteomic adaptations under oxidative stress induced by 5 mM hemin, mimicking midgut conditions. Growth assays [...] Read more.
Serratia plymuthica, isolated from the midgut of Aedes aegypti, displays remarkable resilience to hemin, a toxic hemoglobin byproduct generated during blood digestion. This study explores its proteomic adaptations under oxidative stress induced by 5 mM hemin, mimicking midgut conditions. Growth assays demonstrated that S. plymuthica tolerated hemin concentrations ranging from 5 µM to 1 mM, reaching the stationary phase within approximately 10 h. Colonies exhibited morphological changes—darkened peripheries and translucent halos—suggesting heme accumulation and detoxification. Label-free quantitative proteomics identified 436 proteins, among which 28 were significantly upregulated—including universal stress proteins (USPs), ABC transporters, and flavodoxin—while 54 were downregulated, including superoxide dismutase and several ribosomal proteins. Upregulated proteins were associated with antioxidant defense, heme transport, and redox regulation, whereas downregulated proteins suggested metabolic reprogramming to conserve energy under stress. Functional enrichment analysis revealed significant alterations in transmembrane transport, oxidative stress response, and central metabolism. These findings suggest that S. plymuthica contributes to redox homeostasis in the mosquito gut by mitigating reactive oxygen species (ROS) and detoxifying excess heme, supporting its role as a beneficial symbiont. The observed stress tolerance mechanisms may influence mosquito physiology and vector competence, offering novel insights into mosquito–microbiota interactions and potential microbiota-based strategies for vector control. Full article
(This article belongs to the Section Proteins and Proteomics)
Show Figures

Figure 1

16 pages, 6482 KiB  
Article
Passive Heat Stimuli as a Systemic Training in Elite Endurance Athletes: A New Strategy to Promote Greater Metabolic Flexibility
by Sergi Cinca-Morros, Martin Burtscher, Fernando Benito-Lopez and Jesús Álvarez-Herms
J. Funct. Morphol. Kinesiol. 2025, 10(2), 220; https://doi.org/10.3390/jfmk10020220 - 7 Jun 2025
Viewed by 1344
Abstract
Objectives: The ability to efficiently regulate body temperature is crucial during endurance activities such as trail running, especially during competitive events in hot conditions. Over the past decade, passive hyperthermia exposure has grown significantly in popularity as a means of improving acclimatization and [...] Read more.
Objectives: The ability to efficiently regulate body temperature is crucial during endurance activities such as trail running, especially during competitive events in hot conditions. Over the past decade, passive hyperthermia exposure has grown significantly in popularity as a means of improving acclimatization and performance in hot environments. The present study aims to compare the physiological changes that occur in a group of professional athletes due to passive sauna exposure (80–90 °C) and their own response to maximal aerobic performance. Methods: Twelve professional trail runners (eight men and four women) were tested in three conditions: (i) baseline; (ii) before; and (iii) after (a) passive dry sauna exposure and (b) a maximal endurance test. In both cases, physiological parameters such as heart rate, tympanic temperature, arterial and muscle oxygen saturation, and blood concentrations of glucose, total cholesterol, high-density lipoprotein (HDL) and hemoglobin were measured. Results: Sauna exposure produced similar trends in cardiovascular and metabolic responses to those occurring during exercise, but at a much lower physiological level. Glucose and HDL levels were both significantly elevated (or tended to be so) after sauna and exercise (p < 0.03 and p < 0.01, respectively). Athletes who mobilized the sum of substrates (glucose and HDL) performed the exercise test faster (r = −0.76; p < 0.004). The response of arterial oxygen saturation (decreased) was similar during sauna and exercise, but opposite at the muscular level (increased during sauna and decreased during exercise). Additionally, inter-individual variability in responses was noted for most of the other parameters, suggesting the existence of ‘responders’ and ‘non-responders’ to thermal stimuli. Conclusions: The physiological responses of trained endurance athletes are moderately impacted by passive sauna use. However, individual changes could be correlated with endurance performance and optimizing individualization. Heat stimuli promote different physiological responses in terms of cardiac function, oxygen kinetics and substrate mobilization, albeit to a lesser extent than exercise. Greater substrate mobilization during maximal endurance exercise was found to be correlated with better performance. Further studies are needed to explore the concepts of metabolic flexibility, as described here, and how heat exposure may improve systemic health and performance. Full article
Show Figures

Figure 1

13 pages, 1348 KiB  
Article
Morphometric, Nutritional, and Blood Analyses in Hybrid Striped Bass (Morone chrysops x Morone saxatilis, Walbaum 1972) Reared in a Recirculating Aquaculture System (RAS) Implant in Sicily, Italy
by Francesca Aragona, Syed Sikandar Habib, Francesco Fazio, Alessandro Zumbo, Antonino Costa, Kristian Riolo, Alessia Giannetto and Vincenzo Parrino
Fishes 2025, 10(6), 278; https://doi.org/10.3390/fishes10060278 - 6 Jun 2025
Cited by 1 | Viewed by 400
Abstract
Hybrid striped bass (HSB), a cross between white bass (Morone chrysops) and striped bass (Morone saxatilis), has garnered attention in aquaculture due to its adaptability, rapid growth, and high market value. This study investigates the morphometric, nutritional, and blood [...] Read more.
Hybrid striped bass (HSB), a cross between white bass (Morone chrysops) and striped bass (Morone saxatilis), has garnered attention in aquaculture due to its adaptability, rapid growth, and high market value. This study investigates the morphometric, nutritional, and blood characteristics of HSB reared in a recirculating aquaculture system (RAS) in Sicily, Italy, over a 22-month grow-out period. The fish were managed under standardized feeding and water quality protocols, with weekly monitoring of the physicochemical parameters. A total of 21 clinically healthy fish, averaging 571.33 ± 129.32 in body weight, were randomly sampled in the spring season from a commercial RAS facility equipped with biological filtration, UV sterilization, and seasonally regulated water parameters. The results revealed strong positive correlations between the morphometric parameters and blood indices, such as red blood cell (RBC) count, hemoglobin (Hb) levels, and hematocrit (Hct), highlighting their importance as health indicators. The proximate composition revealed an average moisture content of 75.55 ± 1.49, crude protein at 20.29 ± 0.26, total lipid at 4.25 ± 0.97, and ash content at 1.69 ± 0.17. Additionally, statistical analyses, including a principal component analysis (PCA), identified relationships between body size, nutritional content, and blood parameters, emphasizing the role of body size in influencing nutritional and health outcomes. The findings of this study are crucial for optimizing farming protocols and improving the health and productivity of HSB in RAS under Mediterranean conditions. Full article
(This article belongs to the Special Issue Fish Hematology)
Show Figures

Graphical abstract

21 pages, 2278 KiB  
Review
Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies
by Yunlong Liu, Helian Yang, Mengtian Ren, Qing Yu, Qingyang Xu and Xiuping Fu
Biomolecules 2025, 15(6), 798; https://doi.org/10.3390/biom15060798 - 31 May 2025
Viewed by 663
Abstract
Testicular orphan receptors TR2 and TR4 serve as central regulators of erythropoiesis, orchestrating the entire continuum of erythroid progenitor cell proliferation, differentiation, and maturation. As core components of the direct repeat erythroid determinant (DRED) complex, they activate erythroid-specific transcriptional programs to dynamically control [...] Read more.
Testicular orphan receptors TR2 and TR4 serve as central regulators of erythropoiesis, orchestrating the entire continuum of erythroid progenitor cell proliferation, differentiation, and maturation. As core components of the direct repeat erythroid determinant (DRED) complex, they activate erythroid-specific transcriptional programs to dynamically control the spatiotemporal expression of globin genes. These nuclear receptors not only engage in functional interactions with key erythroid transcription factors GATA1 and KLF1 to coregulate erythroid differentiation and maturation but also recruit epigenetic modifier complexes such as DNMT1 and LSD1 to modulate chromatin states dynamically. Research has established that dysfunctions in TR2/TR4 are implicated in β-thalassemia and sickle cell disease (SCD): β-thalassemia is associated with the defective silencing of γ-globin genes, while in SCD, TR2/TR4 antagonizes BCL11A to reactivate fetal hemoglobin (HbF) expression. This review systematically dissects the molecular regulatory networks of TR2/TR4 in erythroid cells, interprets their dual regulatory properties across different stages of erythroid differentiation, and explores the therapeutic potential of targeting TR2/TR4 for treating erythroid-related disorders such as β-thalassemia and SCD, thereby providing novel directions for hematological disorder therapy. Full article
(This article belongs to the Section Biomacromolecules: Proteins, Nucleic Acids and Carbohydrates)
Show Figures

Figure 1

16 pages, 1882 KiB  
Article
Regulatory Effects of Cinnamon–Pepper–Chili Essential Oil Complex on Growth Performance, Immune Function, Complete Blood Count, and Intestinal Microbiota in Simmental CrossBred Cattle During the Late Fattening Stage
by Tao Zhang, Ting Liu, Jianping Wu, Yining Cheng, Yannan Ma, Wen Chen, Huan Chen, Yunyun Liu and Yunbo Wang
Fermentation 2025, 11(6), 303; https://doi.org/10.3390/fermentation11060303 - 23 May 2025
Viewed by 686
Abstract
This trial aimed to investigate the effects of compound essential oils (EO) on the fattening performance, blood physiological–biochemical indices, and intestinal microbiota in late-fattening Simmental crossbred bulls. Twenty healthy Simmental crossbred bulls (Simmental × Charolais × Angus) with similar initial body weights of [...] Read more.
This trial aimed to investigate the effects of compound essential oils (EO) on the fattening performance, blood physiological–biochemical indices, and intestinal microbiota in late-fattening Simmental crossbred bulls. Twenty healthy Simmental crossbred bulls (Simmental × Charolais × Angus) with similar initial body weights of 442 (±72.49) kg were randomly divided into two groups: a control group (basal diet, CON group) and a compound essential oil group (basal diet + 16 g/head/day, EO group). The trial included a 14-day pre-feeding period and a 42-day experimental period, totaling 56 days. The results showed the following: (1) The EO group exhibited a significantly higher average daily gain (ADG), immunoglobulin A (IgA), immunoglobulin G (IgG), total superoxide dismutase (T-SOD), glutathione peroxidase (GSH-PX), glucose (GLU), dopamine (DA), basophil count (Baso), mean corpuscular hemoglobin (MCH), and platelet distribution width (PDW) compared to the CON group (p < 0.05), while the mean corpuscular volume (MCV) was significantly lower (p < 0.05). (2) Although the compound essential oil supplementation did not alter the relative abundance of major intestinal microbial taxa, it significantly improved the intestinal microbiota structure (p < 0.05), increased fiberdegrading microbiota, and promoted short-chain fatty acid production. (3) The relative abundance of the intestinal microbiota norank_f__UCG-010 showed significant positive correlations with ADG, GSH-PX, IgG, DA, T-SOD, GLU, IgA, and Baso (p < 0.05), while Christensenellaceae_R-7_group abundance was positively correlated with ADG, IgA, and Baso (p < 0.05). In conclusion, the compound essential oil enhances healthy and efficient fattening in beef cattle by improving the intestinal microbial structure, increasing beneficial bacteria, regulating the nutrient metabolism through key bacterial genera, and enhancing the immune function, antioxidant capacity, and energy metabolism levels. Full article
(This article belongs to the Section Industrial Fermentation)
Show Figures

Figure 1

23 pages, 2076 KiB  
Article
Regulatory Roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in Breast Cancer Progression
by Mai S. Degheidy, Amany A. Abou-Elalla, Mahmoud M. Kamel, Shaimaa Abdel-Ghany, Borros Arneth and Hussein Sabit
Curr. Issues Mol. Biol. 2025, 47(5), 377; https://doi.org/10.3390/cimb47050377 - 20 May 2025
Cited by 1 | Viewed by 759
Abstract
Breast cancer (BC) remains the leading cause of cancer-related morbidity and mortality worldwide, necessitating innovative approaches to improve diagnosis, prognosis, and treatment. This case-control study, aimed to evaluate the expression profiles of specific microRNAs (miRNAs)—miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p—in 50 female BC patients [...] Read more.
Breast cancer (BC) remains the leading cause of cancer-related morbidity and mortality worldwide, necessitating innovative approaches to improve diagnosis, prognosis, and treatment. This case-control study, aimed to evaluate the expression profiles of specific microRNAs (miRNAs)—miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p—in 50 female BC patients treated with paclitaxel (PTX) compared to 50 healthy controls. miRNA expression was analyzed using qPCR. The study revealed significant up regulation of these miRNAs in BC patients, with miR-155-5p and miR-21-5p demonstrating the highest diagnostic accuracy (AUC = 0.890 and 0.863, respectively). These miRNAs are implicated in key oncogenic processes, including tumor growth, angiogenesis, metastasis, and chemoresistance, highlighting their potential as non-invasive biomarkers for BC diagnosis and prognosis. Additionally, the study identified significant differences in demographic and biochemical parameters between BC patients and controls, such as lower hemoglobin and RBC counts in patients, indicative of cancer-related anemia, and elevated AST levels. The findings underscore the importance of miRNAs in BC biology and their potential to guide personalized therapeutic strategies. Validation in larger cohorts is recommending and exploring miRNA-based interventions to improve patient outcomes and overcome chemoresistance in BC. Full article
Show Figures

Figure 1

25 pages, 820 KiB  
Review
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring
by Aleksandra Kezić, Selena Gajić, Ana Račić Ostojić, Ivana Bekić, Ana Bontić, Jelena Pavlović, Marko Baralić and Ljiljana Popović
Life 2025, 15(5), 798; https://doi.org/10.3390/life15050798 - 17 May 2025
Viewed by 1522
Abstract
Optimized glycemic management is crucial for controlling atherosclerosis and consequent cardiovascular morbidity in patients with diabetes. Due to the continuous glucose burden from glucose-containing peritoneal dialysis (PD) solutions, PD patients with diabetes experience difficulties in glucose level regulation with glucose hypervariability and worsening [...] Read more.
Optimized glycemic management is crucial for controlling atherosclerosis and consequent cardiovascular morbidity in patients with diabetes. Due to the continuous glucose burden from glucose-containing peritoneal dialysis (PD) solutions, PD patients with diabetes experience difficulties in glucose level regulation with glucose hypervariability and worsening dyslipidemia. Even in non-diabetic PD patients, glucose-containing PD solutions aggravate insulin resistance and cause overweight. Additionally, glucose degradation products (GDP) from glucose-based PD solutions provoke oxidative stress and complex inflammatory processes, leading to chronic deleterious and fibrotic peritoneal membrane changes. In this narrative review, we searched the literature using PubMed, MEDLINE, and Google Scholar over the last three decades to summarize the most important facts relevant to the presented issues, aiming to inform both endocrinologists and nephrologists in providing the best currently available care for people with diabetes on PD. We not only focus on adequate tailoring of insulin therapy adapted at the time of PD exchange with hypertonic glucose solution., but also emphasize the use of continuous glucose monitoring (CGM) that allows assessment of mean glucose values and time spent in normal, hypo, and hyperglycemia. However, the routine use of CGM in PD patients is limited due to high cost, and hemoglobin A1c (HbA1c) analysis is still recommended as a basic clinical tool for the assessment of glycemic control. Possible choices of antidiabetic drugs were considered given the narrowed choice due to contraindications for metformin and sulfonylurea. The other important therapeutic approach in PD patients with diabetes is using glucose-sparing PD regimens based on icodextrin and amino acid PD solutions with the addition of just one or two bags of low glucose concentration PD solution daily. This glucose-sparing approach not only reduces the glucose load and improves glycoregulation with correction of the lipid profile but also maintains the viability of the peritoneal membrane by reducing the harmful effects of GDPs. Full article
(This article belongs to the Special Issue Dialysis)
Show Figures

Figure 1

7 pages, 1772 KiB  
Communication
Nonerythroid Hemoglobin Present in Porcine Testes
by Jeffrey Li, Barbara Jean Nitta and Trish Berger
Animals 2025, 15(10), 1352; https://doi.org/10.3390/ani15101352 - 8 May 2025
Viewed by 321
Abstract
The presence of hemoglobin beta mRNA and protein in the female gonad suggests that hemoglobin beta may be present in the male gonad as well. The frequent occurrence of hemoglobin beta in nonerythroid tissues with hypoxic environments further underscores a potential role for [...] Read more.
The presence of hemoglobin beta mRNA and protein in the female gonad suggests that hemoglobin beta may be present in the male gonad as well. The frequent occurrence of hemoglobin beta in nonerythroid tissues with hypoxic environments further underscores a potential role for hemoglobin beta in the testis to facilitate the regulation of oxygen availability for the developing germ cells and Sertoli cells since they are separated from the blood supply by multiple tissues. The presence of mRNA and protein were evaluated by qPCR and immunohistochemistry, respectively. The mRNA and protein for hemoglobin were detected in juvenile and postpuberal porcine testes. The most intense immunolabelling for the protein was present in testicular interstitial cells, in contrast to previously reported ovarian labelling in close proximity to the gamete and observed in porcine ovaries in the current study. The observed decrease in mRNA expression of hemoglobin beta with age is probably due to the change in testicular composition (increase in seminiferous tubule compartment) with age. The localization of hemoglobin beta in the testis will contribute to future understanding of its potential function in facilitating oxygen availability to seminiferous tubules or reducing oxidative damage. Full article
(This article belongs to the Section Animal Reproduction)
Show Figures

Graphical abstract

9 pages, 660 KiB  
Article
Dietary Supplementation of Astragalus Polysaccharides Modulates Growth Physiology, Metabolic Homeostasis, and Innate Immune Responses in Rice Field Eels (Monopterus albus)
by Chengcheng Wu, Hang Yang, Yutong Yang, Quan Yuan, Weiwei Lv, Gelana Urgesa Ayana, Mingyou Li, Di Su, Wenzong Zhou and Qinghua Zhang
Fishes 2025, 10(5), 213; https://doi.org/10.3390/fishes10050213 - 6 May 2025
Viewed by 1050
Abstract
To investigate the dietary effects of Astragalus polysaccharides (APSs) on the growth performance, lipid metabolism, antioxidant activity, and non-specific immunity of Asian swamp eel (Monopterus albus) during the domestication stage, fish were randomly allocated into quadruplicate groups receiving Tenebrio molitor-based [...] Read more.
To investigate the dietary effects of Astragalus polysaccharides (APSs) on the growth performance, lipid metabolism, antioxidant activity, and non-specific immunity of Asian swamp eel (Monopterus albus) during the domestication stage, fish were randomly allocated into quadruplicate groups receiving Tenebrio molitor-based diets supplemented with Astragalus polysaccharides (APSs) at graded concentrations of 0 (CON), 700 (APS1), 1400 (APS2), and 2100 (APS3) mg/kg body weight for 28 days. The results showed that dietary APSs at 700–1400 mg/kg·bw significantly enhanced the weight gain rate (WG) and decreased the feed conversion ratio (FCR) of M. albus (p < 0.05). Concurrently, hematological analysis revealed that hemoglobin levels increased by 19.9% and 23.0% in the 700 and 1400 mg/kg APS groups, respectively (p < 0.05). In terms of lipid metabolism, supplementation with APSs significantly increased the serum high-density lipoprotein (HDL) content in all treatment groups (p < 0.05). Lower serum triglyceride (TG) levels were found in the APS2 group (p < 0.05), and decreased triglyceride (TG), cholesterol (CHO), and low-density lipoprotein (LDL) levels were displayed in the APS3 group (p < 0.05). Among the antioxidant parameters, the supplementation with 700 mg/kg·bw APSs significantly increased the glutathione peroxidase (GSH-Px) and catalase (CAT) activity levels of M. albus (p < 0.05). The APS2 group had a significantly increased total antioxidant capacity (T-AOC) and CAT activity levels (p < 0.05), and the APS3 group had significantly increased CAT activity levels (p < 0.05). In addition, the APS1 and APS3 groups had significantly reduced malondialdehyde (MDA) levels (p < 0.05). In terms of non-specific immunity, the APS1 and APS2 groups showed significantly increased superoxide dismutase (SOD) and lysozyme (LZM) activity levels of M. albus (p < 0.05), and the addition of 700 mg/kg·bw APSs significantly increased the levels of alkaline phosphatase (AKP) activity (p < 0.05). Furthermore, the levels of acid phosphatase (ACP) activity were significantly increased in all experimental groups (p < 0.05). In conclusion, the optimal APS addition for T. molitor as biocarrier bait is 700 mg/kg, corresponding to 352 mg/kg, which elicits improvements in the growth parameters, lipid homeostasis regulation, oxidative stress mitigation, and innate immune potentiation of M. albus during the domestication stage. Full article
(This article belongs to the Special Issue Advances in Aquaculture Feed Additives)
Show Figures

Figure 1

14 pages, 2244 KiB  
Article
CDK4/6 Inhibitors-Induced Macrocytosis Is Not Associated with Hemolysis and Does Not Impact Hemoglobin Homeostasis
by Tiago Barroso, Leila Costa, Lisa Gonçalves, Vanessa Patel, João Araújo, Inês Pinho, Carolina Monteiro, Miguel Esperança-Martins, Catarina Abreu, Rita Teixeira de Sousa, Helena Pais, Gonçalo Nogueira-Costa, Sofia Torres, Leonor Abreu Ribeiro and Luís Marques da Costa
Cancers 2025, 17(9), 1567; https://doi.org/10.3390/cancers17091567 - 5 May 2025
Viewed by 756
Abstract
Background: CDK 4/6 inhibitors (CDK4/6is) are the first-line treatment for metastatic luminal-like breast cancer (BC). These drugs induce macrocytosis without anemia in most patients. The mechanism for the red blood cell (RBC) changes is unknown. In vitro and animal studies show that RBCs [...] Read more.
Background: CDK 4/6 inhibitors (CDK4/6is) are the first-line treatment for metastatic luminal-like breast cancer (BC). These drugs induce macrocytosis without anemia in most patients. The mechanism for the red blood cell (RBC) changes is unknown. In vitro and animal studies show that RBCs from CDK6-knockout mice have increased membrane fragility, but the clinical impact of CDK4/6is on human RBC lifespan is not known. We sought to determine the impact of CDK4/6is on RBC lifespan and detect changes in the regulation of hemoglobin production. Using the mean corpuscular volume (MCV) measurements at several time points, we can study the evolution of MCV, mean corpuscular hemoglobin concentration (MCHC), and RBC count over time. From this, one can estimate the RBC lifespan under CDK4/6is. Methods: We performed a unicentric retrospective study. Based on published models of RBC population dynamics, we have coded a biologically inspired model which allowed us to extract values for biological parameters, including the RBC lifespan. Results: A total of 122 patients were identified, and 1959 laboratory measurements were analyzed. After the pre-treatment RBCs were replaced, the mean MCV increased by 12.6 femtoliter (fL) (95% Bayesian credible interval [CdI] 13–14), the MCHC increased slightly by 0.69 g/dL (95% CdI 0.42–0.96), and the RBC count decreased by 0.77 × 109/L (95% CdI 0.42 × 109/L–0.96 × 109/L). The net result was a 0.64 g/dL (95% CdI 0.48–0.80) rise in hemoglobin. The mean total RBC lifetime was 118 days (95% CdI 114–122), similar to the value measured in healthy persons. Discussion and Conclusions: These findings suggest that, despite changes in RBC volume, CDK4/6is do not predispose patients to RBC destruction and do not impair regulation of hemoglobin homeostasis. We show that CDK4/6is do not decrease the RBC lifespan in pre-treatment erythrocytes. Unfortunately, this method cannot determine the lifespan of post-treatment RBCs, but further research could help answer this question. Full article
(This article belongs to the Special Issue The Role of Aromatase Inhibitors in Breast Cancer Treatment)
Show Figures

Figure 1

Back to TopTop